Abstract
Objectives To explore the safety and efficacy of front-firing 1470 nm diode laser enucleation in the treatment of non-muscle invasive bladder tumor (NMIBC). Methods Clinical data of 30 patients with NMIBC who treated with front-firing 1 470 nm diode laser enucleation in our hospital from June 2014 to December 2014 were reviewed. Operation time, hemorrhage volume during surgery, operation complications, indwelling catherization time, hospital stay time and recurrence incidence were analyzed. Results All operations were completed successfully without severe complications.The average operating time was (22.5±7.5)min, and hemorrhage volume during surgery was (12.5±2.5)mL. The average indwelling catherization time and hospital stay time was (3.5±1.5)d, (4±2)d , respectively. Following up of 12~18 months postoperative, the recurrence rate was 16.7%. Conclusions Front-firing 1470 nm diode laser enucleation is a safe and effective operation method for the NMIBT. Key words: Urinary Bladder Neoplasms; Lasers
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
